The Clinical Times
The Front Page of Medicine

Latest medical news · page 170

The latest headlines across every section, pulled from official and open-access sources.

KFF Health News · Jun 18, 2026

Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources

Squeezed between their young children and aging parents, the sandwich generation is juggling a lot. KFF Health News Midwest correspondent Cara Anthony discusses embracing her identity as a caregiver and which resources are available to Washington, D.C., residents caring for family members.

KFF Health News · Jun 18, 2026

Arrests of Immigrant Parents Create Mental Health Crisis for Children

An estimated hundreds of thousands of children, many of them U.S. citizens, have been separated from a parent in the Trump administration’s immigration crackdown. Their distress manifests in physical and mental health symptoms including developmental regression, stomachaches, sleep problems, and falling grades. Research points to long-term health consequences.

ECDC (EU) · Jun 18, 2026

Ebola outbreak in DRC and Uganda - ECDC scales up support on the ground

The European Centre for Disease Prevention and Control (ECDC) is expanding its presence on the ground to support areas affected by the current Ebola outbreak, sending additional experts this week to increase assistance and risk assessment activities as the disease continues to impact lives in the Democratic Republic of the Congo (DRC) and Uganda.

MedCity News · Jun 18, 2026

What Is AI Getting Right — and Wrong — in Healthcare’s Revenue Cycle?

AI hasn’t solved all the problems plaguing healthcare’s revenue cycle — but R1’s Lee Kupferman says that it is getting closer, one gray area at a time. The post What Is AI Getting Right — and Wrong — in Healthcare’s Revenue Cycle? appeared first on MedCity News .

MedlinePlus (NLM) · Jun 18, 2026

Safety Guidelines: Helmets

Source: Centers for Disease Control and Prevention Related MedlinePlus Pages: Sports Safety

MedlinePlus (NLM) · Jun 18, 2026

Stay Safe During Physical Activity

Source: Department of Health and Human Services, Office on Women's Health Related MedlinePlus Pages: Sports Safety

JAMA Network Open · Jun 18, 2026

Error in Figure

In the Original Investigation titled “Recent COVID-19 Vaccination and Risk of SARS-CoV-2 Transmission,” published May 15, 2026, Figure 3 contained an error in the vaccine effectiveness 95% CI for primary case participants at 6 months or less since COVID-19 vaccination. The 95% CI should have appeared as 7% to 65%. This article has been corrected.

JAMA Network Open · Jun 18, 2026

Community-Level Digital Health Readiness Index for the US

This cross-sectional study uses public data and expert consensus to develop and validate a reproducible census tract–level index of community digital health readiness integrating socioeconomic conditions, access to care, and digital connectivity.

JAMA Network Open · Jun 18, 2026

The Texas Abortion Ban and Maternal Mental Health

This cross-sectional study examines the association of the implementation of Texas Senate Bill 8, which banned abortions after embryonic cardiac activity, with maternal mental health outcomes.

MedCity News · Jun 17, 2026

KFF: Insurer Participation in ACA Marketplaces Is Down

KFF’s analysis found that the average number of issuers offering plans on the Marketplaces declined to 9 issuers per state in 2026, compared to 9.6 issuers per state in 2025. The post KFF: Insurer Participation in ACA Marketplaces Is Down appeared first on MedCity News .

FDA Newsroom · Jun 17, 2026

FDA Approves First Single-Dose Generic Treatment for Influenza

The U.S. Food and Drug Administration today approved the first generic of Xofluza (baloxavir marboxil) tablets, the first single-dose treatment for acute uncomplicated influenza and prophylaxis in patients 5 years of age and older.

MedCity News · Jun 17, 2026

FDA Reversal on uniQure Gene Therapy Is Another Sign of Renewed Regulatory Flexibility

UniQure is preparing to seek accelerated FDA approval for its Huntington’s disease gene therapy, a move that follows the FDA’s reversal of its prior position calling for another clinical trial. This gene therapy is the latest in a growing list of rare disease treatments to receive reconsideration from an FDA that appears to be swinging back to regulatory flexibility. The post FDA Reversal on uniQure Gene Therapy Is Another Sign of Renewed Regulatory Flexibility appeared first on MedCity News .

← NewerOlder →

Back to the live front page